Cases 1 - 10 of 889
Harrell v. CENCORA, INC. et al
as 2:2024cv02524
Plaintiff:
Mark Harrell
Defendant:
CENCORA, INC., THE LASH GROUP, LLC, BRISTOL-MYERS SQUIBB COMPANY and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Contract Dispute
PETTIFORD v. CENCORA, INC. et al
as 2:2024cv02228
Plaintiff:
MICHELLE PETTIFORD
Defendant:
CENCORA, INC., THE LASH GROUP, LLC, BRISTOL-MYERS SQUIBB PATIENT ASSISTANCE FOUNDATION, INC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Contract Dispute
Pfizer Inc. et al v. Apotex, Inc. et al
as 1:2024cv00621
Plaintiff:
Pfizer Inc., Pfizer Ireland Pharmaceutials and Bristol-Myers Squibb Company
Defendant:
Apotex, Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Changzhou Pharmaceutical Factory
as 1:2024cv00623
Plaintiff:
Pfizer Inc., Pfizer Ireland Pharmaceuticals and Bristol-Myers Squibb Company
Defendant:
Changzhou Pharmaceutical Factory
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION et al v. PRIME THERAPEUTICS LLC
as 2:2024cv04479
Petitioner:
CELGENE CORPORATION and BRISTOL-MYERS SQUIBB COMPANY
Respondent:
PRIME THERAPEUTICS LLC
Celgene Corporation et al v. Prime Therapeutics LLC
as 1:2024mc00131
Petitioner:
Celgene Corporation and Bristol-Myers Squibb Company
Respondent:
Prime Therapeutics LLC
Mayo Clinic et al v. Celgene Corporation et al
as 2:2023cv22321
Plaintiff:
Mayo Clinic and Lifepoint Corporate Services, General Partnership
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
INTERMOUNTAIN HEALTH, INC. v. CELGENE CORPORATION et al
as 2:2023cv22117
Plaintiff:
INTERMOUNTAIN HEALTH, INC.
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
